FCI
SEEL

Financial Counselors Inc’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Financial Counselors Inc’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3
Closed -$7K – 512
2022
Q2 		$7K Hold
3
– – ﹤0.01% 501
2022
Q1 		$8K Hold
3
– – ﹤0.01% 515
2021
Q4 		$16K Hold
3
– – ﹤0.01% 516
2021
Q3 		$24K Hold
3
– – ﹤0.01% 538
2021
Q2 		$26K Buy
+3
New +$49.3K ﹤0.01% 528

Other funds holding SEEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Financial Counselors Inc's SEEL Position: Q3 2022 in Review

Financial Counselors Inc sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q3 2022, closing a stake of 3 shares — an estimated $7K sold.

Financial Counselors Inc first reported a position in SEEL in Q2 2021 and held it in 5 quarters. The position peaked at $26K in Q2 2021. 68 funds tracked by Wall St. Rank hold SEEL as of Q3 2022.

  • Financial Counselors Inc reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Financial Counselors Inc sold 3 Seelos Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $7K.
  • Financial Counselors Inc first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Financial Counselors Inc's Seelos Therapeutics, Inc. Common Stock position peaked at $26K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Financial Counselors Inc's 13F filing for Q3 2022, filed 1 Nov 2022.